Drug Pipeline

Macupatide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT07215559
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination…		 Trial sites expanded: 38 -> 42 locations
2026-05-15 NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in…		 Enrollment increased: 1217 -> 1481 participants
2026-05-15 NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in…		 Trial arms changed: 5 -> 6
2026-05-15 NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in…		 date change Primary completion pushed: 2026-06 -> 2027-09
2026-05-15 NCT06143956
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in…		 date change Completion pushed: 2026-09 -> 2028-02
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-15 NCT07589608 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in… Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 2
3
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06143956 A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in… Obesity Recruiting
NCT07215559 A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination… Obesity Recruiting
NCT07589608 A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in… Overweight Not Yet Recruiting
Sponsors Running Macupatide Trials
Eli Lilly and Company (3)
Disease Areas
Obesity (3) Diabetes (1)
Get alerts when Macupatide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free